DWTX – dogwood therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Dogwood Therapeutics (NASDAQ:DWTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
DWTX: Financing Secures Funding Through Phase 2b Data Readout [Yahoo! Finance]
Form 8-K Dogwood Therapeutics, For: Mar 26
Form 10-K Dogwood Therapeutics, For: Dec 31
Form 8-K Dogwood Therapeutics, For: Mar 18
Form 8-K Dogwood Therapeutics, For: Mar 11
Form 4 Dogwood Therapeutics, For: Mar 05 Filed by: Grosswald Ralph
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.